Health Care/Hospital
TIME Names Carrier's OptiClean a Best Invention of 2020
OptiClean Dual-Mode Air Scrubber & Negative Air Machine recognized for its rapid innovation to help create healthy indoor environments PALM BEACH GARDENS, Fla., Nov. 20, 2020 /PRNewswire/ -- Carrier Global Corporation (NYSE: CARR) a leading global provider of healthy, safe and sustainable buildi...
2020-11-20 01:48
5327
MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management
CLEVELAND, Nov. 20, 2020 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) program. Pet...
2020-11-20 01:45
2562
Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology
Summarizes ciraparantag's expected mechanism of action, pharmacokinetic, and pharmacodynamic characteristics and its proof of concept as an anticoagulant reversal agent LUXEMBOURG and ZUG, Switzerland, Nov. 20, 2020 /PRNewswire/ -- Covis Group S.à r.l. ("Covis") today announced that data demonst...
2020-11-20 01:26
1878
Mitochondrial-Targeted Antioxidant Protects Genomes Against DNA Damage in Exercising Humans
AUCKLAND, New Zealand, Nov. 19, 2020 /PRNewswire/ -- Healthy male participants who take a novel antioxidant that specifically targets the powerhouse of the cells, mitochondria, sees attenuation in exercise induced mitochondria DNA (mtDNA) damage in lymphocytes and muscle. Mitochondria has been s...
2020-11-19 23:07
1064
LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System
UDINE, Italy, Nov. 19, 2020 /PRNewswire/ -- LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) to start the clinical trial of the SMR Stemless Reverse Shoulder System. The FDA approval allows LimaCorporate t...
2020-11-19 23:00
2129
West China's Chongqing Liangjiang New Area seeks global talents both online and offline
CHONGQING, China, Nov. 19, 2020 /PRNewswire/ -- From November 21 to 22, the Chongqing Talents Conference 2020 will be held inWest China's Chongqing Liangjiang New Area. Heavyweight domestic and foreign guests from political, business, science and technology, education, medicine and health, and fi...
2020-11-19 22:01
1554
endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows
SAN FRANCISCO and ANN ARBOR, Mich., Nov. 19, 2020 /PRNewswire/ -- endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase study ...
2020-11-19 22:00
2352
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction
BEIJING, Nov. 19, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that it has entered into a definitive Agreement and Plan of Merger (the "Merg...
2020-11-19 21:09
8816
RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
Pre-scheduled independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia Enrollment in the 270-patient global Phase 2/3 COVID-19 study with opaganib is more than 50% complete ...
2020-11-19 20:21
4495
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
AUSTIN, Nov. 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases, has announced that Dr.Mark Eccleston, a founding sci...
2020-11-19 20:00
7231
Praram 9 Hospital Achieves GHA's COVID-19 Certification of Conformance for Medical Travel
WEST PALM BEACH, Fla., Nov. 19, 2020 /PRNewswire/ -- Praram 9 Hospital ( https://www.praram9.com/), a state-of-the-art facility located in Bangkok, Thailand, was awarded Global Healthcare Accreditation's Certification of Conformance with COVID-19 Guidelines for Medical Travel Programs. The Global...
2020-11-19 18:00
2259
111, Inc. Announces Third Quarter 2020 Unaudited Financial Results
SHANGHAI, Nov. 19, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quarter endedSepte...
2020-11-19 18:00
7535
CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity
HONG KONG, Nov. 19, 2020 /PRNewswire/ -- Gut microbiota plays an important role in regulating immunity against infections. People who suffer from imbalance in gut microbiota (dysbiosis) are more susceptible to viral infection and other complications. An earlier study by the Faculty of Medicine of...
2020-11-19 17:13
2874
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room
VEENENDAAL, The Netherlands, Nov. 19, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced Elekta Studio with its launch of the ImagingRing, an advanced interventional CT system that revolves around the patient and enables clinicians to conduct the entire brachytherapy workflow - including ap...
2020-11-19 15:16
4067
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China
SHANGHAI and SAN FRANCISCO, Nov. 19, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and Sagimet Biosciences Inc. jointly announced today that they have completed patient enrollment in the ASC40 (TVB-2640) Phase 2 NASH trial inChina. The tr...
2020-11-19 08:30
2805
INEX Innovate's iGene Laboratory announces new personalised medicine genotyping analysis project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology
SINGAPORE, Nov. 19, 2020 /PRNewswire/ -- INEX Innovate's iGene Laboratory (iGene) announced today a project withEli Lilly and Company's (NYSE: LLY) research unitLilly Centre for Clinical Pharmacology (LCCP), which conducts early phase clinical trials in healthy participants and patients inSingapo...
2020-11-19 08:00
2615
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy signal in 40 hospitalized patients with severe COVID-19 pneumonia A parallel global Phase 2/3 study with orally administered opaganib for severe COVID-19 is approximately 50% enrolled - on track to e...
2020-11-19 07:00
2572
Mibelle Biochemistry's Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market Lauded by Frost & Sullivan
The company's active ingredient product lines meet consumer expectations of quality, performance, and sustainability LONDON, Nov. 18, 2020 /PRNewswire/ -- Based on its recent analysis of the global personal care active ingredients market, Frost & Sullivan recognizes Mibelle AG Biochemistry with t...
2020-11-18 23:40
1994
Deep Longevity Launches The First Longevity Medicine Course For Physicians
HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...
2020-11-18 23:00
9530
Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII
SHANGHAI, Nov. 18, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the final closing of Qiming Venture Partners Fund VII, a$1.2 billion fund focuses on early-stage Healthcare and TMT investments. As of today, this is the largest VC fund raising in 2020 which primarily focuses onChina...
2020-11-18 21:15
2685
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7869
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6964
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4256
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2874